Lipoprotein receptors in the vascular wall

Current Opinion in Lipidology

Volumn 15, Issue 2, 2004, Pages 175-181

  Herz, Joachim ^a   Hui, David Y ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Endothelium; Macrophage; Oxidation; Plaque; Smooth muscle cell

Indexed keywords

CHOLESTEROL; LIPID; LIPOPROTEIN RECEPTOR;

ATHEROSCLEROSIS; BLOOD VESSEL WALL; CHOLESTEROL TRANSPORT; ENDOTHELIUM; HUMAN; LIPID TRANSPORT; MACROPHAGE; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION;

ARTERIOSCLEROSIS; BLOOD VESSELS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, LIPOPROTEIN;

EID: 1842557570     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200404000-00010     Document Type: Review

References (42)

1. Kume N, Kita T. Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis. Curr Opin Lipidol 2001; 12:419-423.
2. Yagyu H, Lutz EP, Kako Y, et al. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J Biol Chem 2002; 277:10037-10043.
3. Obunike JC, Lutz EP, Li Z, et al. Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor. J Biol Chem 2001, 278:8934-8941.
4. Hembrough TA, Ruiz JF, Papathanassiu AE, et al. Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor. J Biol Chem 2001; 278:12241-12248.
5. Li Y, Lu W, Marzolo MP, Bu G. Differential functions of members of the low density lipoprotein receptor family suggested by their distinct endocytosis rates. J Biol Chem 2001; 278:18000-18006.
6. Yuhanna IS, Zhu Y, Cox BE, et al. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nature Med 2001; 7:853-857.
7. Drab M, Verkade P, Elger M, et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001; 293:2449-2452.
8. Suzuki H, Kurihara Y, Takeya M, et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997; 386:292-296.
9. Tontonoz P, Nagy L, Alvarez JG, et al. PPARgamma promotes monocyte/ macrophage differentiation and uptake of oxidized LDL. Cell 1998; 93:241-252.
10. Nagy L, Tontonoz P, Alvarez JG, et al. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1996; 93:229-240.
11. Lee CH, Chawla A, Urbiztondo N, et al. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 2003; 302:453-157. The nuclear receptor PPARδ functions in the control of atherogenic inflammation through an unconventional mechanism.
12. Wentworth P Jr, McDunn JE, Wentworth AD, et al. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 2002; 296:2195-2199. Ozone formation by antibody-mediated catalysis and oxidative burst by neutrophils is identified as a novel oxidative pathway with potential roles in the vessel wall.
13. Llorente-Cortes V, Martinez-Gonzalez J, Badimon L. LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells. Arterioscler Thromb Vasc Bol 2000; 20:1572-1579.
14. Gardai SJ, Xiao YQ, Dickinson M, et al. By binding SIRPalpha or calreticulin/ CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003; 115:13-23. LRP1/CD91 is proposed as an activator of inflammatory/stress activated signaling in macrophages.
15. Su HP, Nakada-Teukui K, Tosello-Trampont AC, et al. Interaction of CED-6/ GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP). J Biol Chem 2002; 277:11772-11779. GULP, the mammalian orthologue of the Caenorhabditis elegans CED6 gene, is a PTB domain adaptor protein that may function in the control of apoptotic cell removal through LRP1.
16. Fazio S, Babaev VR, Murray AB, et al. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci USA 1997; 94:4647-4652.
17. Swertfeger DK, Hui DY. Apolipoprotein E receptor binding versus heparan sulfate proteoglycan binding in its regulation of smooth muscle cell migration and proliferation. J Biol Chem 2001; 276:25043-25046.
18. Hiltunen TP, Yla-Herttuala S. Expression of lipoprotein receptors in atherosclerotic lesions. Atherosclerosis 1996; 137:361-366.
19. Zhu Y, Bujo H, Yamazaki H, et al. Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro. Circulation 2002; 105:1630-1636. LR11 is shown to be present in smooth muscle cells and modulates migration and binding to uPA and the uPAR.
20. Tacken PJ, Delsing DJM, Gijbels MJJ, et al. VLDL receptor deficiency enhances intimal thickening after vascular injury but does not affect atherosclerotic lesion area. Atherosclerosis 2002; 162:103-110. This describes a role of the VLDL receptor in the vessel wall in regulation of atherosclerosis and intimal thickening. The study showed that the determinants for the two processes are not necessarily similar.
21. Swertfeger DK, Bu G, Hui DY. Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration. J Biol Chem 2002; 277:4141-4146.
22. Webb DJ, Nguyen DHD, Gonias SL. Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration. J Cell Sci 2000; 113:123-134.
23. Kanaki T, Bujo H, Hirayama S, et al. Expression of LR11, a mosaic LDL receptor family member, is markedly increased in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1999; 19:2667-2695.
24. Nykjaer A, Petersen CM, Moller B, et al. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase plasminogen activator inhibitor type-1 complex: evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J Biol Chem 1992; 267:14543-14546.
25. Wijnberg MJ, Quax PHA, Nieuwenbroek NME, Verheijen JH. The migration of human smooth muscle eels in vitro is mediated by plasminogen activation and can be inhibited by alpha2-macroglobulin receptor associated protein. Thromb Haemost 1997; 76:660-886.
26. Ishigami M, Swertfeger DK, Granholm N, Hui DY. Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase. J Biol Chem 1996; 273:20156-20161.
27. Zhu Y, Hui DY. Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A. J Biol Chem 2003; 278:38257-36263. Apolipoprotein E binding to LRP1 inhibits smooth muscle cell migration and this process is mediated by activation of cAMP and protein kinase A-dependent pathways.
28. Nassar T, Akkawi S, Shina A, et al. The in vitro and in vivo effect of tPA and PAJ-1 on blood vessel tone. Blood (in press).
29. Nassar T, Haj-Yehia A, Akkawi S, et al. Binding of urokinase to low density lipoprotein-related receptor (LRP) regulates vascular smooth muscle cell contraction. J Biol Chem 2002; 277:40499-40504. LRP1 also interacts with urokinase and uPA to regulate smooth muscle cell functions.
30. Barnes H, Larsen B, Tyers M, van der Geer P. Tyrosine-phosphorylated low density lipoprotein receptor-related protein 1 (LRP1) associates with the adaptor protein SHC in SRC-transformed cells. J Biol Chem 2001; 278:19119-19125.
31. Boucher P, Liu P, Gotthardt M, Hiesberger T, Anderson RGW, Herz J. Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low density lipoprotein receptor-related protein in caveolae. J Biol Chem 2002; 277:15507-15513.
32. Loukinova E, Ranganathan S, Kuznetsov S, et al. Platelet-derived growth factor (PDGF)-inducad tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function between LRP and the PDGF. J Biol Chem 2002; 277:15499-15506.
33. May P, Bock HH, Nimpf J, Herz J. Differential glycosylation regulates processrg of lipoprotein receptors by gamma-secretase. J Biol Chem 2003; 276:37386-37392. This study showed that differential and tissue-specific glycosylation are physiological switches that can modulate the diverse biological functions of LRP1.
34. May P, Reddy YK, Herz J. Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J Biol Chem 2002; 277:18736-18743.
35. Li Y, Marzolo MP, van Kerkhof P, et al. The YXXL motif, but not the two NPXY motifs, serves as the dominant endocytosis signal for low density lipoprotein receptor-related protein. J Biol Chem 2000; 275:17187-17194.
36. Trommsdorff M, Borg JP, Margolis B, Herz J. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J Biol Chem 1996; 273:33556-33560.
37. Gotthardt M, Trommsdorff M, Navitt MF, et al. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J Biol Chem 2000; 275:25616-25624.
38. Mishra SK, Keyel PA, Hawryluk MJ, et al. Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor. Embo J 2002; 21:4915-4926.
39. Morris SM, Cooper JA. Disabled-2 colocalizes with the LDLR in clathrin-coated the and interacts with AP-2. Traffic 2001; 2:111-123.
40. He G, Gupta S, Yi M, et al. ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin, and AP-2. J Biol Chem 2002; 277:44044-44049. This paper identifies ARH as an adaptor protein that couples LDL receptor to the endocytic machinery.
41. Li Y, van Kerkhof P, Marzolo MP, et al. Identification of a major cyclic AMP-dependent protein kinase A phosphorylation site within the cytoplasmic tail of the low-density lipoprotein receptor-related protein: Implication for receptor-mediated endocytosis. Mol Cell Biol 2001; 21:1185-1195.
42. Boucher P, Gotthardt M, Li W-P, et al. LRR role in vascular wall integrity and protection from atherosclerosis. Science 2003; 300:329-332. This paper documents the physiological role of LRP1 in vascular protection and preventing atherosclerosis by controlling PDGF receptor activation.